ArticleNeurology and therapy2026

Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment.

Min Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.